FORA Capital’s ResMed RMD Stock Holding History

FORA Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Sell	6,357 -2,496	-28%	-$517K	0.09%	201
2026 Q1	$1.99M	Sell	8,853 -1,069	-11%	-$266K	0.15%	168
2025 Q4	$2.39M	Buy	9,922 +9,067	+1,060%	+$2.32M	0.29%	91
2025 Q3	$234K	Sell	855 -15,156	-95%	-$4.14M	0.04%	419
2025 Q2	$4.13M	Buy	+16,011	New	+$3.82M	0.46%	52
2023 Q4	–	Sell	-25,057	Closed	-$3.71M	–	612
2023 Q3	$3.71M	Buy	25,057 +21,172	+545%	+$3.83M	0.33%	90
2023 Q2	$849K	Sell	3,885 -5,093	-57%	-$1.14M	0.12%	180
2023 Q1	$1.97M	Buy	8,978 +914	+11%	+$198K	0.2%	144
2022 Q4	$1.68M	Buy	8,064 +5,967	+285%	+$1.31M	0.27%	101
2022 Q3	$458K	Buy	+2,097	New	+$477K	0.09%	263
2022 Q1	–	Sell	-2,698	Closed	-$703K	–	615
2021 Q4	$703K	Sell	2,698 -5,386	-67%	-$1.4M	0.27%	109
2021 Q3	$2.13M	Buy	+8,084	New	+$2.21M	0.54%	52
2020 Q4	–	Sell	-2,055	Closed	-$352K	–	1107
2020 Q3	$352K	Buy	+2,055	New	+$379K	0.23%	93
2020 Q1	–	Sell	-1,631	Closed	-$253K	–	1289
2019 Q4	$253K	Buy	+1,631	New	+$235K	0.03%	567

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

FORA Capital's RMD Position: Q2 2026 in Review

FORA Capital reduced its ResMed (RMD) stake by 28% in Q2 2026, selling an estimated $517K and leaving 6,357 shares worth $1.24M. The position accounts for 0.09% of the portfolio, ranked #201.

FORA Capital first reported a position in RMD in Q4 2019 and has held it in 14 quarters since. The position peaked at $4.13M in Q2 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

FORA Capital held 6,357 shares of ResMed worth $1.24M as of Q2 2026.
FORA Capital sold 2,496 ResMed shares in Q2 2026, an estimated $517K.
ResMed made up 0.09% of FORA Capital's portfolio in Q2 2026, its #201 holding.
FORA Capital first reported a position in ResMed in Q4 2019 and has held it in 14 quarters since.
FORA Capital's ResMed position peaked at $4.13M in Q2 2025.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.